The next board meeting for Amylyx Pharmaceuticals Inc is on 10 Jun 2025 for the purpose of Goldman Sachs 46th Annual Global Healthcare ConferenceSee details
Amylyx Pharmaceuticals Inc has a share price target of US$ 11, revenue growth forecast of -99.9%, and profit growth estimate of 48.9% for FY26, based on top 7 analyst calls.